Hypnotherapy With Audiofiles for Children and Adolescents With Disorders of Gut-brain Interactions in Sweden -a Feasibility Study
Launched by KAROLINSKA INSTITUTET · Jul 2, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new treatment option called hypnotherapy, delivered through audio files, for children and adolescents in Sweden who have certain gut-related issues, like irritable bowel syndrome or functional abdominal pain. The goal is to see if this method is effective and practical for helping these young patients manage their symptoms. The researchers have tailored the treatment to suit Swedish families, building on previous studies done in the Netherlands. If successful, this approach could make it easier for more children to access effective treatments without needing to meet with a psychologist in person.
To be eligible for the study, participants should be aged between 2 to 18 years and diagnosed with specific gastrointestinal disorders. They also need to understand Swedish, and at least one parent must as well. The study is currently recruiting participants, and those involved can expect to use audio files for their hypnotherapy, which is a low-cost treatment option that could save families money and reduce wait times for care. Overall, this study hopes to provide new, effective treatment choices for children struggling with gut-brain interaction disorders.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis: irritable bowel syndrome, functional abdominal pain, functional dyspepsia (following the Rome IV diagnostic criteria)
- • The participant and at least one of the parents must understand Swedish
- Exclusion Criteria:
- • other medical condition that better explains the symtoms
- • Absence from school \>40% and/or psychiatric diagnosis that is judged to be more primary than the gastrointestinal problems, in these cases the children/young people are judged to need more intensive and multi-professional treatment
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, , Sweden
Patients applied
Trial Officials
Ola Olén, MD PhD prof
Principal Investigator
Department of clinical epidemiology, Karolinska Institutet
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported